Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 1999, p. 3761-3763, Vol. 37, No. 11
Institute of Medical Microbiology, Medical
School Hannover, 30625 Hannover, Germany
Received 19 February 1999/Returned for modification 10 July
1999/Accepted 31 July 1999
Despite decontamination, overgrowth by pseudomonads renders
cultural isolation of mycobacteria from respiratory specimens of
patients with cystic fibrosis (CF) difficult or impossible. We
performed a prospective study by comparing levels of reduction of
overgrowth and recovery of mycobacteria using either pretreatment with
N-acetyl-L-cysteine (NALC)-NaOH alone or
pretreatment with NALC-NaOH and then with oxalic acid. From 406 specimens of 148 CF patients, 11 specimens were positive for
mycobacteria, 5 of which grew mycobacteria after
decontamination by either procedure. Three specimens grew mycobacteria
only after decontamination with NALC-NaOH, whereas three specimens grew
mycobacteria only after treatment with NALC-NaOH followed by oxalic
acid but were overgrown after decontamination with NALC-NaOH. Thus,
inactivation of mycobacteria by the more aggressive
oxalic acid treatment offsets its beneficial effect of reducing the
proportion of cultures overgrown with microorganisms other than mycobacteria.
Once considered quite rare,
nontuberculous mycobacteria are being recovered with increasing
frequency from respiratory specimens of adolescent and adult patients
suffering from cystic fibrosis (CF) (1, 4). In particular,
Mycobacterium chelonae, Mycobacterium abscessus,
and Mycobacterium fortuitum appear to play an important role
in this group of patients, although other nontuberculous mycobacteria
such as Mycobacterium avium, Mycobacterium
intracellulare, and Mycobacterium kansaii have been
isolated as well (2, 3, 5).
A variety of other microorganisms colonize or infect the respiratory
tracts of CF patients and often hamper the recovery of mycobacteria,
since they rapidly overgrow mycobacterial cultures. Pseudomonas
aeruginosa, in particular, is present in the respiratory tracts of
up to 80% of CF patients. Typically, it survives routine sputum
decontamination with NALC-NaOH
(N-acetyl-L-cysteine-2% sodium hydroxide).
Thus, for eradication of overgrowing bacteria, the most commonly used
laboratory manual recommends treatment with 5% oxalic acid for samples
from the respiratory tracts of CF patients (7).
Whittier and colleagues demonstrated that NALC-NaOH treatment followed
by oxalic acid for initial decontamination significantly reduced
overgrowth by P. aeruginosa (8). In a subsequent
report those authors evaluated their results in a multicenter study
involving 20 participating laboratories by sending out for
mycobacterial culture a panel of five specimens seeded with
pseudomonads and with mycobacteria (9). From their results
Whittier et al. concluded that decontamination of the seeded specimens
with NALC-NaOH and oxalic acid yielded a significant reduction in
bacterial overgrowth and improved recovery of mycobacteria. Thus,
pretreatment with NALC-NaOH and then with oxalic acid prior to
culturing for mycobacteria was recommended as a decontamination
procedure for specimens from the respiratory tracts of CF patients.
In their original studies Whittier and colleagues pointed out that the
combination of NALC-NaOH and oxalic acid, although very effective in
eradicating overgrowing bacteria, might also reduce recovery of
mycobacteria, especially from low-titer specimens. Thus, we designed a
prospective study to examine the recovery rate of mycobacteria from
respiratory specimens of CF patients following the use of either of two
decontamination methods: treatment with NALC-NaOH or treatment with
NALC-NaOH followed by oxalic acid.
Specimens were obtained from 148 patients attending the CF clinic of
the Medical School Hannover between May and November 1998. Respiratory
specimens, including sputa, tracheal aspirates, and specimens recovered
by bronchoscopy, were processed in the Department of Medical
Microbiology for acid-fast bacilli by smearing and culturing. All
mycobacterial specimens were cultured in BACTEC MGIT 960 (Becton
Dickinson, Sparks, Md.). Positive cultures were subjected to species
identification by PCR-mediated amplification of the 16S rRNA gene and
direct sequence determination as described previously (6). A
total of 428 specimens were studied: 14 specimens in an initial pilot
study and 414 specimens in a subsequent prospective study.
The recovery rate of M. chelonae that had been inoculated
into clinical specimens contaminated with various microorganisms was
assessed in the initial pilot study. Fourteen specimens from CF
patients that grew either pseudomonads (11 specimens), proteins (1 specimen), molds (1 specimen), or both pseudomonads and molds (1 specimen) were seeded with M. chelonae. A cell suspension of M. chelonae was adjusted to match a 0.5 McFarland standard,
and 0.05 ml of this volumen was added for every 1.0 ml of specimen volume. Each specimen was divided into two equal aliquots and decontaminated with NALC-NaOH or NALC-NaOH followed by oxalic acid. For
the NALC-NaOH method, specimens were combined with an equal volume of
0.5% NALC-2% NaOH and vortexed for at least 15 min at room
temperature. The specimen was washed with distilled water, and one half
was used for inoculation of MGIT vials and staining for acid-fast
bacilli, whereas the other half was subjected to further
decontamination with oxalic acid. An equal volume of 5% oxalic acid
was added to the second fraction. This mixture was vortexed and washed
with phosphate-buffered saline. With pH paper, the specimen was
neutralized by addition of 4% NaOH to a pH of about 7 prior to being
stained and cultured.
After decontamination with NALC-NaOH, 3 of 14 specimens (21%) grew
exclusively M. chelonae. Almost 80% of the specimens
remained contaminated. In contrast, after decontamination with
NALC-NaOH followed by oxalic acid, none of the specimens was
contaminated but all grew M. chelonae. Thus, the rate of
overgrowing bacteria was dramatically reduced whereas the viability of
M. chelonae appeared to be unchanged. This result
prompted us to compare the yields of mycobacteria by both
decontaminating procedures in a prospective study. For a period of 6 months all specimens from the respiratory tracts of CF patients sent to
our department were divided and subjected either to standard
decontamination with NALC-NaOH or to decontamination with NALC-NaOH
followed by oxalic acid.
Of 406 specimens, 169 did not show any
growth after decontamination with NALC-NaOH (42%) whereas 237 were
contaminated (58%). In contrast, after treatment with NALC-NaOH
followed by oxalic acid, no bacteria were recovered from 300 specimens
(74%) whereas bacteria were recovered from 106 samples (26%).
Overall, decontamination with NALC-NaOH followed by oxalic acid
significantly reduced the proportion of contaminated specimens. We next
wished to address the question of whether the reduced proportion of
overgrown specimens after decontamination with NALC-NaOH followed by
oxalic acid resulted in an increased recovery of mycobacteria. Of
the 414 specimens investigated, 11 were positive for mycobacteria
(Table 1). However, only five specimens
were positive after either procedure. Three specimens showed growth of
mycobacteria after treatment with NALC-NaOH but remained sterile
after treatment with NALC-NaOH followed by oxalic acid. Three specimens
became positive after treatment with NALC-NaOH followed by oxalic acid
but were contaminated when NALC-NaOH alone was used.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Recovery of Mycobacteria from Patients with
Cystic Fibrosis
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Profiles of CF patients whose respiratory specimens
(collected between May and November 1998) grew
Mycobacterium speciesa
This finding supports the assumption that oxalic acid may cause false-negative results, especially from low-titer specimens. Although the contamination rate was significantly reduced with NALC-NaOH and oxalic acid, the overall sensitivity of mycobacterial recovery remained the same: three specimens were positive only after treatment with NALC-NaOH followed by oxalic acid but were overgrown with other microorganisms when NALC-NaOH alone was used; however, three specimens grew mycobacteria only after treatment with NALC-NaOH and revealed no bacterial growth when both NALC-NaOH and oxalic acid were used. These three specimens were also smear negative, demonstrating that oxalic acid poses a particular problem for low-titer specimens. Thus, the negative effect on the recovery rate of mycobacteria by the more aggressive oxalic acid treatment offsets its beneficial effect in reducing the proportion of cultures overgrown with microorganisms other than mycobacteria.
In summary, we provide evidence that bacterial decontamination with NALC-NaOH followed by oxalic acid results in an impressive reduction of bacterial overgrowth. Overall recovery of mycobacteria, however, was not improved. Based on this experience, we are currently investigating a two-step decontamination procedure. In the first step, respiratory specimens from CF patients are decontaminated with NALC-NaOH and, without further decontamination, the specimens are inoculated for culture. In the second step, only those samples overgrown with microorganisms other than mycobacteria (about half of all specimens) are subjected to a second decontamination with oxalic acid.
| |
ACKNOWLEDGMENTS |
|---|
We thank the medical technicians, in particular, N. Quiram, of the mycobacterial laboratory of the department of Medical Microbiology of the Medical School Hannover.
F.-C. Bange was supported by a postdoctoral fellowship of the Infektionsforschung und AIDS-Stipendiumprogramm of the German government.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Phone: 49-511-532-4352. Fax: 49-511-532-4366. E-mail: bange{at}mikrobio.mh-hannover.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aitken, M. L.,
W. Burke,
G. McDonald,
C. Wallis,
B. Ramsey, and C. Nolan.
1993.
Nontuberculous mycobacterial disease in adult cystic fibrosis patients.
Chest
103:1096-1099 |
| 2. | Boxerbaum, B. 1980. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J. Pediatr. 96:689-691[Medline]. |
| 3. | Griffith, D. E., W. M. Girard, and R. J. Wallace, Jr. 1993. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. Am. Rev. Respir. Dis. 147:1271-1278[Medline]. |
| 4. |
Hjelte, L.,
B. Petrini,
G. Kallenius, and B. Strandvik.
1990.
Prospective study of mycobacterial infections in patients with cystic fibrosis.
Thorax
45:397-400 |
| 5. |
Kilby, J. M.,
P. H. Gilligan,
J. R. Yankaskas,
W. E. Highsmith,
L. J. Edwards, and M. R. Knowles.
1992.
Nontuberculous mycobacteria in adult patients with cystic fibrosis.
Chest
102:70-75 |
| 6. |
Kirschner, P.,
B. Springer,
U. Vogel,
A. Meier,
A. Wrede,
M. Kiekenbeck,
F.-C. Bange, and E. C. Bottger.
1993.
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.
J. Clin. Microbiol.
31:2882-2889 |
| 7. | Metchock, B. G., F. S. Nolte, and R. J. Wallace, Jr. 1999. Mycobacterium, p. 1665-1685. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C |
| 8. |
Whittier, S.,
R. L. Hopfer,
M. R. Knowles, and P. H. Gilligan.
1993.
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.
J. Clin. Microbiol.
31:861-864 |
| 9. | Whittier, S., K. Olivier, P. Gilligan, M. Knowles, P. Della-Latta, and The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. 1997. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 35:2706-2708[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»